Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer
暂无分享,去创建一个
M. Esteller | M. Nichelatti | K. Bencardino | A. Sartore-Bianchi | S. Siena | C. Moutinho | A. Cassingena | A. Amatu | G. Chirico | F. Rusconi | A. Esposito | Alessandro Belotti